2018-2023 Global Penicillin and Streptomycin Market Report (Status and Outlook)

August 2018 | 115 pages | ID: 296143BE84DEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Penicillin and Streptomycin market for 2018-2023.

Penicillin-Streptomycin is used to supplement cell culture media to control bacterial contamination.
Penicillin streptomycin solution has been used as a supplement in different types of media, including RGC (retinal ganglion cells) culture, ?-MEM (minimum essential medium) growth medium, Dulbecco?s modified Eagle?s medium (DMEM)/nutrient mixture F-12 Ham, DMEMand DMEM/F-12 + GlutaMax.
Over the next five years, LPI(LP Information) projects that Penicillin and Streptomycin will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Penicillin and Streptomycin market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Penicillin
• Streptomycin

Segmentation by application:

• Throat Infections
• Meningitis
• Tuberculosis Treatment

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Astellas Pharma
• GlaxoSmithKline
• MiddleBrook Pharmaceuticals
• Johnson & Johnson
• Merck
• Gilead Sciences
• Toyama Chemical
• Eli Lilly
• Astra Zeneca
• Takeda Pharmaceutical

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Penicillin and Streptomycin market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Penicillin and Streptomycin market by identifying its various subsegments.
• Focuses on the key global Penicillin and Streptomycin players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Penicillin and Streptomycin with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Penicillin and Streptomycin submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Penicillin and Streptomycin Market Size 2013-2023
  2.1.2 Penicillin and Streptomycin Market Size CAGR by Region
2.2 Penicillin and Streptomycin Segment by Type
  2.2.1 Penicillin
  2.2.2 Streptomycin
2.3 Penicillin and Streptomycin Market Size by Type
  2.3.1 Global Penicillin and Streptomycin Market Size Market Share by Type (2013-2018)
  2.3.2 Global Penicillin and Streptomycin Market Size Growth Rate by Type (2013-2018)
2.4 Penicillin and Streptomycin Segment by Application
  2.4.1 Throat Infections
  2.4.2 Meningitis
  2.4.3 Tuberculosis Treatment
2.5 Penicillin and Streptomycin Market Size by Application
  2.5.1 Global Penicillin and Streptomycin Market Size Market Share by Application (2013-2018)
  2.5.2 Global Penicillin and Streptomycin Market Size Growth Rate by Application (2013-2018)

3 GLOBAL PENICILLIN AND STREPTOMYCIN BY PLAYERS

3.1 Global Penicillin and Streptomycin Market Size Market Share by Players
  3.1.1 Global Penicillin and Streptomycin Market Size by Players (2016-2018)
  3.1.2 Global Penicillin and Streptomycin Market Size Market Share by Players (2016-2018)
3.2 Global Penicillin and Streptomycin Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PENICILLIN AND STREPTOMYCIN BY REGIONS

4.1 Penicillin and Streptomycin Market Size by Regions
4.2 Americas Penicillin and Streptomycin Market Size Growth
4.3 APAC Penicillin and Streptomycin Market Size Growth
4.4 Europe Penicillin and Streptomycin Market Size Growth
4.5 Middle East & Africa Penicillin and Streptomycin Market Size Growth

5 AMERICAS

5.1 Americas Penicillin and Streptomycin Market Size by Countries
5.2 Americas Penicillin and Streptomycin Market Size by Type
5.3 Americas Penicillin and Streptomycin Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Penicillin and Streptomycin Market Size by Countries
6.2 APAC Penicillin and Streptomycin Market Size by Type
6.3 APAC Penicillin and Streptomycin Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Penicillin and Streptomycin by Countries
7.2 Europe Penicillin and Streptomycin Market Size by Type
7.3 Europe Penicillin and Streptomycin Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Penicillin and Streptomycin by Countries
8.2 Middle East & Africa Penicillin and Streptomycin Market Size by Type
8.3 Middle East & Africa Penicillin and Streptomycin Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL PENICILLIN AND STREPTOMYCIN MARKET FORECAST

10.1 Global Penicillin and Streptomycin Market Size Forecast (2018-2023)
10.2 Global Penicillin and Streptomycin Forecast by Regions
  10.2.1 Global Penicillin and Streptomycin Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Penicillin and Streptomycin Forecast by Type
10.8 Global Penicillin and Streptomycin Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Astellas Pharma
  11.1.1 Company Details
  11.1.2 Penicillin and Streptomycin Product Offered
  11.1.3 Astellas Pharma Penicillin and Streptomycin Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Astellas Pharma News
11.2 GlaxoSmithKline
  11.2.1 Company Details
  11.2.2 Penicillin and Streptomycin Product Offered
  11.2.3 GlaxoSmithKline Penicillin and Streptomycin Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 GlaxoSmithKline News
11.3 MiddleBrook Pharmaceuticals
  11.3.1 Company Details
  11.3.2 Penicillin and Streptomycin Product Offered
  11.3.3 MiddleBrook Pharmaceuticals Penicillin and Streptomycin Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 MiddleBrook Pharmaceuticals News
11.4 Johnson & Johnson
  11.4.1 Company Details
  11.4.2 Penicillin and Streptomycin Product Offered
  11.4.3 Johnson & Johnson Penicillin and Streptomycin Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Johnson & Johnson News
11.5 Merck
  11.5.1 Company Details
  11.5.2 Penicillin and Streptomycin Product Offered
  11.5.3 Merck Penicillin and Streptomycin Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Merck News
11.6 Gilead Sciences
  11.6.1 Company Details
  11.6.2 Penicillin and Streptomycin Product Offered
  11.6.3 Gilead Sciences Penicillin and Streptomycin Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Gilead Sciences News
11.7 Toyama Chemical
  11.7.1 Company Details
  11.7.2 Penicillin and Streptomycin Product Offered
  11.7.3 Toyama Chemical Penicillin and Streptomycin Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Toyama Chemical News
11.8 Eli Lilly
  11.8.1 Company Details
  11.8.2 Penicillin and Streptomycin Product Offered
  11.8.3 Eli Lilly Penicillin and Streptomycin Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 Eli Lilly News
11.9 Astra Zeneca
  11.9.1 Company Details
  11.9.2 Penicillin and Streptomycin Product Offered
  11.9.3 Astra Zeneca Penicillin and Streptomycin Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 Astra Zeneca News
11.10 Takeda Pharmaceutical
  11.10.1 Company Details
  11.10.2 Penicillin and Streptomycin Product Offered
  11.10.3 Takeda Pharmaceutical Penicillin and Streptomycin Revenue, Gross Margin and Market Share (2016-2018)
  11.10.4 Main Business Overview
  11.10.5 Takeda Pharmaceutical News

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Penicillin and Streptomycin
Figure Penicillin and Streptomycin Report Years Considered
Figure Market Research Methodology
Figure Global Penicillin and Streptomycin